Recent evidence suggests that increased expression of the reprogramming stem cell transcription factor SOX2 makes PCa cells resistant to hormone blockade by the antiandrogen Enza (Mu et al., 2017). The gene discussed is SOX2; the disease is posterior cortical atrophy.